Literature DB >> 10565577

Modulation of sodium currents in rat CA1 neurons by carbamazepine and valproate after kindling epileptogenesis.

M Vreugdenhil1, W J Wadman.   

Abstract

PURPOSE: To determine the modulation of sodium currents in hippocampal CA1 neurons by carbamazepine (CBZ) and valproate (VPA), before and after kindling epileptogenesis.
METHODS: Voltage-dependent sodium current was measured in isolated hippocampal CA1 neurons, by using the whole-cell voltage-clamp technique. CBZ (15-100 microM) or VPA (0.5-5 mM) was applied by bath perfusion. Cells from fully kindled rats were compared with controls, 1 day and 5 weeks after the tenth generalized seizure.
RESULTS: CBZ did not affect sodium current activation but selectively shifted the voltage dependence of steady-state inactivation to more hyperpolarized potentials. One day after the last kindled generalized seizure, the shift induced by 15 microM CBZ was 2.1+/-0.5 mV (mean +/- SEM; n = 20) compared with 4.3+/-0.3 mV (n = 16; p<0.001) in matched controls. The EC50 of the concentration-effect relation was 57+/-6 microM compared with 34+/-2 microM (p<0.01) in controls. Five weeks after kindling, these values had recovered to a level not different from control. VPA induces at a relatively high concentration a similar but smaller shift in voltage dependence of inactivation than does CBZ. After kindling, the shift induced by 2 mM VPA (2.8+/-0.6 mV; n = 19) was not different from controls (3.0+/-0.5 mV; n = 22). The EC50 for VPA was 2.6+/-0.3 mM compared with 2.5+/-0.4 mM in controls.
CONCLUSIONS: Both CBZ and VPA selectively modulate the voltage dependence of sodium current steady-state inactivation and as a consequence reduce cellular excitability. The effect of CBZ was reduced immediately after kindling epileptogenesis, apparently by a reduced affinity of its receptor. In contrast, the shift induced by VPA was not different at any stage after kindling epileptogenesis. The change in CBZ sensitivity after kindling is related to epileptic activity rather than to the epileptic state, because it almost completely recovers in a period without seizures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565577     DOI: 10.1111/j.1528-1157.1999.tb02034.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  19 in total

1.  How to explain multidrug resistance in epilepsy?

Authors:  Wolfgang Löscher
Journal:  Epilepsy Curr       Date:  2005 May-Jun       Impact factor: 7.500

2.  Net worth of networks: specificity in anticonvulsant action.

Authors:  Calvin J Schneider; Ivan Soltesz
Journal:  Epilepsy Curr       Date:  2015 Jan-Feb       Impact factor: 7.500

3.  Reduction of spike generation frequency by cooling in brain slices from rats and from patients with epilepsy.

Authors:  Sadahiro Nomura; Hiroyuki Kida; Yuya Hirayama; Hirochika Imoto; Takao Inoue; Hiroshi Moriyama; Dai Mitsushima; Michiyasu Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-17       Impact factor: 6.200

Review 4.  Ion channels as drug targets in central nervous system disorders.

Authors:  A M Waszkielewicz; A Gunia; N Szkaradek; K Słoczyńska; S Krupińska; H Marona
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  Attenuation of phospholipid signaling provides a novel mechanism for the action of valproic acid.

Authors:  Xuehua Xu; Annette Müller-Taubenberger; Kathryn E Adley; Nadine Pawolleck; Vivian W Y Lee; Claudia Wiedemann; Talvinder S Sihra; Markus Maniak; Tian Jin; Robin S B Williams
Journal:  Eukaryot Cell       Date:  2007-04-13

Review 6.  Animal models of limbic epilepsies: what can they tell us?

Authors:  Douglas A Coulter; Dan C McIntyre; Wolfgang Löscher
Journal:  Brain Pathol       Date:  2002-04       Impact factor: 6.508

Review 7.  Management of the patient with medically refractory epilepsy.

Authors:  Tiziana Granata; Nicola Marchi; Erin Carlton; Chaitali Ghosh; Jorge Gonzalez-Martinez; Andreas V Alexopoulos; Damir Janigro
Journal:  Expert Rev Neurother       Date:  2009-12       Impact factor: 4.618

Review 8.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

9.  Effects of developmental alcohol and valproic acid exposure on play behavior of ferrets.

Authors:  Thomas E Krahe; Claudio C Filgueiras; Alexandre E Medina
Journal:  Int J Dev Neurosci       Date:  2016-05-18       Impact factor: 2.457

10.  Animal models for the development of new neuropharmacological therapeutics in the status epilepticus.

Authors:  Ed Martín; Ma Pozo
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.